# FDA Inspection 1224863 - Charles River Laboratories Inc - November 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/charles-river-laboratories-inc/59612d57-7014-46bd-8bc8-b5d83e6f53e1
Source feed: FDA_Inspections

> FDA Inspection 1224863 for Charles River Laboratories Inc on November 17, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1224863
- Company Name: Charles River Laboratories Inc
- Inspection Date: 2023-11-17
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1294508 - 2025-10-17](https://www.keypedia.com/records/fda_inspections/charles-river-laboratories-inc/d0b299ab-d1cb-40c7-bbe1-9709baca33b4)
- [FDA Inspection 1260289 - 2025-02-07](https://www.keypedia.com/records/fda_inspections/charles-river-laboratories-inc/a3efc927-fe52-4ed6-9694-4526464c95fa)
- [FDA Inspection 1258366 - 2024-10-11](https://www.keypedia.com/records/fda_inspections/charles-river-laboratories-inc/84934c8a-5981-47bc-816e-c45143e2953f)
- [FDA Inspection 911880 - 2015-01-23](https://www.keypedia.com/records/fda_inspections/charles-river-laboratories-inc/d46a9a9d-31b0-406f-ae45-f9c744c4baea)
- [FDA Inspection 606003 - 2009-07-30](https://www.keypedia.com/records/fda_inspections/charles-river-laboratories-inc/23523c98-1725-4e35-9630-07c796bde1b1)

Company: https://www.keypedia.com/companies/charles-river-laboratories-inc/876b68d9-6285-4039-8732-05f876b5d911

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d